Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Structure Therapeutics Inc ADR’s current trading price is -63.02% away from its 52-week high, while its distance from the 52-week low is 26.93%. The stock’s price range during this period has varied between $13.22 and $45.37. The company, active in the Healthcare sector, saw a trading volume of around 0.58 million for the day, considerably lower average daily volume of 0.76 million observed over the last three months.
Structure Therapeutics Inc ADR (GPCR) has a current stock price of $16.78. During the previous trading session, the stock witnessed a notable rise, reaching a high of $120.0 after opening at $16.78. The stock’s low for the day was $37.5, and it eventually closed at $17.59.
Structure Therapeutics Inc ADR’s stock has had a tumultuous market performance.
How Financial Performance Impacts Market Capitalization
Structure Therapeutics Inc ADR (GPCR) has experienced a quarterly decline of -38.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 965.52M and boasts a workforce of 163 employees.
Decoding Analysts’ Ratings for Structure Therapeutics Inc ADR
As of right now, 8 analysts are rating Structure Therapeutics Inc ADR as a BUY, 5 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.03, with a change in price of -3.75. Similarly, Structure Therapeutics Inc ADR recorded 874,945 in trading volume during the last 100 days, posting a change of -18.27%.
How GPCR’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for GPCR stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
GPCR Stock Stochastic Average
As of today, the raw stochastic average of Structure Therapeutics Inc ADR over the past 50 days is 0.24%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 0.57%. Additionally, the Stochastic %K and %D values for the company were 5.14% and 7.64%, respectively, over the past 20 days.
GPCR Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -55.12% this year. Over the last six months, there has been a stronger performance of -44.01%. The price of GPCR leaped by -17.60% during the last 30 days period. For the last 5-days stocks have slided -8.16%.
